Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2% 0.5%’.
The above information is a part of company’s filings submitted to BSE.